Choledocholithiasis (Common Bile Duct Stones)

Choledocholithiasis refers to one or more gallstones lodged in the common bile duct (Baiu & Hawn, JAMA, 2018). It is the most common cause of bile duct obstruction and one of the principal complications of gallstone disease, occurring in roughly 10% to 20% of patients with symptomatic gallstones (Patel & Jepsen, American Family Physician, 2024; Buxbaum et al., ASGE Guideline, 2019). Among patients undergoing gallbladder removal for symptomatic stones, concurrent common bile duct stones are found in about 10% to 18% of cases, and in up to 20% of those operated on urgently for acute cholecystitis (Qadir & Saadat, Current Gastroenterology Reports, 2026).

Most common bile duct stones are secondary — they form in the gallbladder and migrate into the duct — while a smaller number are primary, forming within the duct itself (Gurusamy et al., Cochrane Database, 2015). The clinical spectrum is broad: some stones pass silently into the intestine and cause no symptoms, while others obstruct bile flow and produce biliary pain, jaundice, cholangitis, or pancreatitis (Portincasa et al., Internal and Emergency Medicine, 2023). Because the complications can be life-threatening, current guidelines recommend removing all identified common bile duct stones — whether or not they are causing symptoms — in patients fit to tolerate the procedure (Qadir & Saadat, Current Gastroenterology Reports, 2026; Zhang et al., Surgical Endoscopy, 2023).

‍

Choledocholithiasis develops when a stone occupies the common bile duct (Gurusamy et al., Cochrane Database, 2015):

• Secondary stones (most common) — gallstones that form in the gallbladder and migrate through the cystic duct into the common bile duct (Gurusamy et al., Cochrane Database, 2015).

• Primary stones — stones that form within the bile duct itself, less common in Western populations and typically associated with bile stasis, infection, or ductal strictures (Gurusamy et al., Cochrane Database, 2015).

• Underlying lithogenesis — the same process that drives gallstone formation: cholesterol supersaturation of bile, inadequate bile salts, and reduced biliary contractility, shaped by diet, hormones, and genetic predisposition (Buxbaum et al., ASGE Guideline, 2019).

‍

Because most common bile duct stones originate in the gallbladder, the risk factors mirror those for gallstone disease, with advancing age being a particularly important contributor to ductal stones (Portincasa et al., Internal and Emergency Medicine, 2023):

• Older age — the incidence of choledocholithiasis rises with age

• Pre-existing gallstones and prior biliary symptoms

• Female sex

• Obesity, the metabolic syndrome, and insulin resistance

• Rapid weight loss or crash dieting

• Pregnancy, oral contraceptive, or estrogen use

• Family history and genetic predisposition

• Conditions causing pigment stones — chronic hemolysis, cirrhosis, and certain ileal diseases (Kleinubing et al., Cochrane Database, 2018)

‍

The common bile duct carries bile from the liver and gallbladder to the duodenum to aid fat digestion (Baiu & Hawn, JAMA, 2018). When a stone lodges in the duct, it obstructs this outflow, and bile backs up toward the liver (Portincasa et al., Internal and Emergency Medicine, 2023). This produces the characteristic biochemical picture of obstruction — rising bilirubin (causing jaundice), alkaline phosphatase, GGT, and the liver transaminases (ALT/AST) — which may improve if the obstruction is transient and the stone passes (Portincasa et al., Internal and Emergency Medicine, 2023).

Persistent obstruction sets the stage for two major complications. Stagnant, obstructed bile allows bacteria from the intestine to invade the biliary tree, producing ascending cholangitis, a potentially life-threatening infection (Patel & Jepsen, American Family Physician, 2024). If a stone obstructs the shared channel at the sphincter of Oddi, pancreatic enzymes back up and trigger gallstone pancreatitis — making choledocholithiasis the leading cause of acute pancreatitis (Buxbaum et al., ASGE Guideline, 2019).

‍

Untreated common bile duct stones can lead to (Qadir & Saadat, Current Gastroenterology Reports, 2026; Patel & Jepsen, American Family Physician, 2024):

• Ascending cholangitis — bacterial infection of the obstructed biliary tree; can cause critical illness and septic shock

• Gallstone (biliary) pancreatitis — the leading cause of acute pancreatitis

• Obstructive jaundice — from blocked bile flow

• Hepatic abscess

• Secondary biliary cirrhosis — from long-standing obstruction

• Recurrent biliary pain and complications — roughly 50% of patients with symptomatic bile duct stones develop recurrent pain or complications without stone removal (Lammert et al., Nature Reviews Disease Primers, 2016)

‍

Presentation ranges from no symptoms to severe illness, depending on whether complications develop (Portincasa et al., Internal and Emergency Medicine, 2023):

• Pain — right-upper-quadrant or epigastric pain that tends to be more prolonged than typical biliary colic and resolves when the stone passes or is removed; intermittent pain can indicate a floating or partially obstructing stone (Portincasa et al., Internal and Emergency Medicine, 2023).

• Jaundice — yellowing of the skin and eyes from a backed-up bile duct, often with dark urine and pale, clay-colored stools (Gurusamy et al., Cochrane Database, 2015).

• Nausea and vomiting (Portincasa et al., Internal and Emergency Medicine, 2023).

• Charcot's triad — right-upper-quadrant pain, fever, and jaundice together signal cholangitis, a biliary emergency (Patel & Jepsen, American Family Physician, 2024).

Some common bile duct stones are entirely asymptomatic and discovered only on imaging or liver testing — but they still carry a meaningful risk of later complications (Lammert et al., Nature Reviews Disease Primers, 2016).

‍

Diagnosis combines liver biochemistry, imaging, and risk stratification (Zhang et al., Surgical Endoscopy, 2023):

• Liver function tests — elevated bilirubin, alkaline phosphatase, GGT, and transaminases suggest obstruction; a normal combined panel has a high negative predictive value (>97%) for ruling out duct stones (Kleinubing et al., Cochrane Database, 2018).

• Transabdominal ultrasound — first-line imaging; a dilated bile duct and visualized stones raise suspicion, though sensitivity for stones at the far end of the duct is limited (Qadir & Saadat, Current Gastroenterology Reports, 2026).

• Risk stratification — professional-society (ASGE) criteria combine clinical features, labs, and ultrasound to classify patients as low, intermediate, or high probability of having a duct stone, which guides next steps (Buxbaum et al., ASGE Guideline, 2019).

• MRCP (magnetic resonance cholangiopancreatography) — a highly accurate, noninvasive test for intermediate-risk patients (Buxbaum et al., ASGE Guideline, 2019).

• Endoscopic ultrasound (EUS) — a semi-invasive test with excellent sensitivity (89–94%) and specificity (94–95%), useful to confirm stones before committing to ERCP and to avoid unnecessary procedures (Wang et al., Digestive Diseases and Sciences, 2026).

• ERCP — both diagnostic and therapeutic, but reserved for patients with a high probability of stones because of its procedural risk (Buxbaum et al., ASGE Guideline, 2019).

‍

Prolonged biliary pain, abnormal liver tests, or jaundice must be distinguished from (Baiu & Hawn, JAMA, 2018; Portincasa et al., Internal and Emergency Medicine, 2023):

• Biliary colic (uncomplicated gallbladder attack)

• Acute cholecystitis

• Ascending cholangitis and gallstone pancreatitis (complications of duct stones)

• Biliary or pancreatic-head tumors causing malignant obstruction

• Benign biliary strictures and primary sclerosing cholangitis

• Viral or drug-induced hepatitis

• Peptic ulcer disease

• Mirizzi syndrome — extrinsic duct compression by a gallbladder-neck stone

‍

Choledocholithiasis is treated procedurally, not with lifestyle change; however, the same measures that reduce gallstone formation lower the chance of developing duct stones in the first place (Lammert et al., Nature Reviews Disease Primers, 2016):

• Maintain a healthy weight and avoid rapid/crash weight loss — and when major weight loss is planned (including after bariatric surgery), ursodeoxycholic acid can reduce gallstone formation (Lammert et al., Nature Reviews Disease Primers, 2016).

• Favor a higher-fiber, lower-refined-fat diet and manage metabolic risk factors (Kleinubing et al., Cochrane Database, 2018).

Once a stone is in the duct, diet cannot clear it or substitute for definitive treatment — the stone must be removed to prevent cholangitis and pancreatitis (Qadir & Saadat, Current Gastroenterology Reports, 2026).

‍

The goals are to clear the duct and then remove the gallbladder to prevent recurrence (Baiu & Hawn, JAMA, 2018):

• ERCP with sphincterotomy and stone extraction — the mainstay of treatment, clearing the duct in 85–90% of cases with an overall adverse-event rate of about 5% and mortality under 1% in expert hands (Qadir & Saadat, Current Gastroenterology Reports, 2026; ASGE Standards of Practice Committee, 2015).

• Laparoscopic cholecystectomy after clearance — gallbladder removal should be routinely offered after endoscopic duct clearance, and performing it early (within about 72 hours) reduces recurrent biliary events compared with delaying it (Lammert et al., Nature Reviews Disease Primers, 2016).

• Single-stage laparoscopic common bile duct exploration with cholecystectomy — clears the duct and removes the gallbladder in one operation; an effective option where surgical expertise is available (Qadir & Saadat, Current Gastroenterology Reports, 2026).

• Intraoperative cholangiography — imaging during cholecystectomy to detect and address stones found at the time of surgery (Portincasa & Wang, Yamada's Textbook of Gastroenterology, 2022).

• Difficult stones — large (>15 mm), multiple, or awkwardly positioned stones may require large-balloon papillary dilation, mechanical lithotripsy, or cholangioscopy-guided laser/electrohydraulic lithotripsy (Qadir & Saadat, Current Gastroenterology Reports, 2026; ASGE Standards of Practice Committee, 2015).

• Urgent biliary decompression — in cholangitis, early ERCP to drain the infected, obstructed duct is critical and reduces mortality (ASGE Standards of Practice Committee, 2015).

• ERCP/sphincterotomy without cholecystectomy — reserved for select patients at high surgical risk; biliary symptoms recur roughly twice as often when the gallbladder is left in place, with a 5-year risk of needing cholecystectomy as high as 15% (ASGE Standards of Practice Committee, 2015).

‍

Anyone with upper-abdominal pain that is prolonged or recurring, or who develops yellowing of the skin or eyes, dark urine, or pale stools, should be evaluated promptly, since these suggest a bile duct obstruction (Portincasa et al., Internal and Emergency Medicine, 2023). A known history of gallstones with new jaundice or abnormal liver tests warrants timely assessment for a migrated duct stone, which tends to recur and can progress to serious complications without treatment (Lammert et al., Nature Reviews Disease Primers, 2016).

‍

Seek emergency care for (Patel & Jepsen, American Family Physician, 2024; Baiu & Hawn, JAMA, 2018):

• Fever with jaundice and right-upper-quadrant pain (Charcot's triad) — suggesting cholangitis

• Severe, persistent upper-abdominal or mid-back pain — possible gallstone pancreatitis

• Jaundice, dark urine, or clay-colored stools

• Confusion, low blood pressure, or rapid heart rate — possible biliary sepsis

These features indicate a biliary emergency requiring hospital evaluation, antibiotics when infection is suspected, and urgent duct clearance (ASGE Standards of Practice Committee, 2015).

‍

After the duct is cleared and the gallbladder removed, the long-term outlook is very good, and most patients return to a normal, unrestricted diet (Baiu & Hawn, JAMA, 2018). Removing the gallbladder eliminates the main source of future stones, substantially reducing the chance of recurrent duct stones and biliary complications; leaving the gallbladder in place roughly doubles the rate of recurrent biliary symptoms (ASGE Standards of Practice Committee, 2015). A minority of patients can still form stones within the duct over time, so persistent or recurrent symptoms after treatment warrant re-evaluation (Gurusamy et al., Cochrane Database, 2015).

‍

With timely duct clearance and gallbladder removal, the prognosis for choledocholithiasis is excellent, and endoscopic stone extraction succeeds in more than 90% of cases with a low complication rate in experienced hands (ASGE Standards of Practice Committee, 2015). The main risks come from complications present at diagnosis — cholangitis or pancreatitis — and from leaving stones untreated, where roughly half of patients develop recurrent pain or complications (Lammert et al., Nature Reviews Disease Primers, 2016). Because experience and procedural volume strongly influence ERCP success and safety, treatment at a high-volume biliary center improves outcomes (Lammert et al., Nature Reviews Disease Primers, 2016).

‍

Choledocholithiasis sits at the intersection of endoscopy and minimally invasive surgery, and optimal management depends on accurate risk stratification and the right sequence of interventions (Buxbaum et al., ASGE Guideline, 2019). As a board-certified surgeon with advanced expertise in minimally invasive and robotic foregut and biliary surgery, Dr. Nestor de la Cruz-Muñoz, MD, FACS, DABOM uses guideline-based risk assessment — combining liver chemistries, ultrasound, and when indicated MRCP or EUS — to identify duct stones efficiently and avoid unnecessary procedures (Buxbaum et al., ASGE Guideline, 2019; Wang et al., Digestive Diseases and Sciences, 2026). He coordinates timely ERCP for duct clearance with early laparoscopic (or robotic) cholecystectomy, offers single-stage common bile duct exploration where appropriate, and adheres to safe-cholecystectomy principles to minimize the risk of bile-duct injury (Qadir & Saadat, Current Gastroenterology Reports, 2026; Lammert et al., Nature Reviews Disease Primers, 2016). For patients presenting with cholangitis or gallstone pancreatitis, he provides urgent, multidisciplinary biliary care aimed at rapid decompression and definitive treatment (ASGE Standards of Practice Committee, 2015).

‍